Dosage: 60 to 100 mcg per day Frequency: Once daily or split into two doses Administration: Subcutaneous or intramuscular Cycle length: 4 to 6 weeks maximum Time off: Longer than time on Important: IGF-1 LR3 dosage should not exceed 100 mcg per day according to most research protocols
Santalla et al., 2014) and not in CPTII deficiency individuals ( An extensive description of the methods for diagnosing CPTII deficiency (i.e., clinical presentation, pathobiochemical characteristics, molecular genetic aspects, detectable biomarkers and genotype-phenotype analysis) has been recently published by Sigauke et al., 2003) or functional evaluations, able to show abnormalities in lactate levels, VO 2 max capacity and respiratory exchange ratio (R) during an ergometric incremental test, which may underline the defective mitochondrial oxidative functionality (Tarnopolsky, 2016)
This results in a reduction in particle size and an increase in surface area, which translates into a higher extraction rate (65)
Onuki Y, Bhardwaj U, Papadimitrakopoulos F, Burgess DJ
Ann Pharmacother, 1998;32:1044-52 122
Loren Pickart, who discovered the existence of copper tripeptide in 1973, and Anna Margolina, the copper peptide GHK-Cu: Stimulates blood vessel and nerve outgrowth Increases collagen, elastin and glycosaminoglycan synthesis Supports the function of dermal fibroblasts Improves tissue repair for skin, lung connective tissue, boney tissue, liver and stomach lining
